Moxalactam therapy for a wide spectrum of bacterial infections in adults.
We evaluated the efficacy and toxicity of moxalactam during treatment of 45 documented infections in 36 patients. A majority of patients received 4.5 g of moxalactam per day. There was a good clinical response in 42 of the 45 (94%) infections, including 3 bacteremias, 20 skin and soft tissue infecti...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1981
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181515/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6457555/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.5.740 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|